{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:14Z","timestamp":1777984334401,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272109"],"award-info":[{"award-number":["82272109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472010"],"award-info":[{"award-number":["82472010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiovascular Ultrasound Innovation Team of Yunnan Province","award":["202305AS350021"],"award-info":[{"award-number":["202305AS350021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02257-8","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:52:43Z","timestamp":1772884363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-dimensional echocardiography-derived myocardial mechanistic insights into obstructive hypertrophic cardiomyopathy with moderate septal hypertrophy"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuwei","family":"Bao","sequence":"first","affiliation":[]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[]},{"given":"Jeffrey B.","family":"Geske","sequence":"additional","affiliation":[]},{"given":"Si","family":"Fang","sequence":"additional","affiliation":[]},{"given":"Shiliang","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Liming","family":"Xia","sequence":"additional","affiliation":[]},{"given":"Youbin","family":"Deng","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-0811","authenticated-orcid":false,"given":"Yani","family":"Liu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"publisher","unstructured":"Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, et al. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the american heart association\/american college of cardiology joint committee on clinical practice guidelines. Circulation. 2024;149. https:\/\/doi.org\/10.1161\/CIR.0000000000001250.","DOI":"10.1161\/CIR.0000000000001250"},{"key":"2257_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","volume":"389","author":"J Veselka","year":"2017","unstructured":"Veselka J, Anavekar NS, Charron P. Hypertrophic obstructive cardiomyopathy. Lancet. 2017;389:1253\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(16)31321-6.","journal-title":"Lancet"},{"key":"2257_CR3","doi-asserted-by":"publisher","first-page":"e240555","DOI":"10.1148\/ryct.240555","volume":"7","author":"R Gandhi","year":"2025","unstructured":"Gandhi R, Ooi EL, Mugwagwa A, Botrous C, Raman B. A Review of Multimodality Imaging in Hypertrophic Cardiomyopathy: Diagnosis, Risk Stratification, and Therapeutic Guidance. Radiology: Cardiothorac Imaging. 2025;7:e240555. https:\/\/doi.org\/10.1148\/ryct.240555.","journal-title":"Radiology: Cardiothorac Imaging"},{"key":"2257_CR4","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Authors\/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733\u201379. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284.","journal-title":"Eur Heart J"},{"key":"2257_CR5","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","volume":"74","author":"S Neubauer","year":"2019","unstructured":"Neubauer S, Kolm P, Ho CY, Kwong RY, Desai MY, Dolman SF, et al. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. J Am Coll Cardiol. 2019;74:2333\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1057.","journal-title":"J Am Coll Cardiol"},{"key":"2257_CR6","doi-asserted-by":"publisher","unstructured":"Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circ: Cardiovascular Imaging. 2015;8. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003132","DOI":"10.1161\/CIRCIMAGING.115.003132"},{"key":"2257_CR7","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1093\/eurheartj\/ehac439","volume":"43","author":"JB Geske","year":"2022","unstructured":"Geske JB, Stephens EH, Dearani JA. Hypertrophic cardiomyopathy with extreme outflow tract obstruction. Eur Heart J. 2022;43:4518\u20134518. https:\/\/doi.org\/10.1093\/eurheartj\/ehac439.","journal-title":"Eur Heart J"},{"key":"2257_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ejcts\/ezab097","volume":"60","author":"E Lapenna","year":"2021","unstructured":"Lapenna E, Nisi T, Carino D, Bargagna M, Ruggeri S, Zancanaro E, et al. Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results. Eur J Cardiothorac Surg. 2021;60:244\u201351. https:\/\/doi.org\/10.1093\/ejcts\/ezab097.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2257_CR9","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","volume":"67","author":"MV Sherrid","year":"2016","unstructured":"Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. J Am Coll Cardiol. 2016;67:1846\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.071.","journal-title":"J Am Coll Cardiol"},{"key":"2257_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ejcts\/ezx398","volume":"53","author":"A Nguyen","year":"2018","unstructured":"Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, et al. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?\u2020. Eur J Cardiothorac Surg. 2018;53:582\u20139. https:\/\/doi.org\/10.1093\/ejcts\/ezx398.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2257_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ihj.2022.09.003","volume":"74","author":"ME Maghawry","year":"2022","unstructured":"Maghawry ME, Shehata L, Muhammad Abdullah Elbelbesy IE, Abdelrashid R, ZeinElabdeen MA. Tissue tracking of segmental strain as a predictor of provoked dynamic left ventricular outflow tract obstruction. Indian Heart J. 2022;74:414\u20139. https:\/\/doi.org\/10.1016\/j.ihj.2022.09.003.","journal-title":"Indian Heart J"},{"key":"2257_CR12","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/eurheartj\/ehad637","volume":"44","author":"E Braunwald","year":"2023","unstructured":"Braunwald E, Saberi S, Abraham TP, Elliott PM, Olivotto I. Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy. Eur Heart J. 2023;44:4622\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehad637.","journal-title":"Eur Heart J"},{"key":"2257_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396:759\u201369. https:\/\/doi.org\/10.1016\/S0140-6736(20)31792-X.","journal-title":"Lancet"},{"key":"2257_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/RCT.0000000000000977","volume":"45","author":"L Huang","year":"2021","unstructured":"Huang L, Que L, Xi Y, Zhuang J, Yuan H, Liu H, et al. Myocardial Mechanics Parameters That Predict Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic Resonance Feature Tracking Analysis. J Comput Assist Tomogr. 2021;45:65\u201372. https:\/\/doi.org\/10.1097\/RCT.0000000000000977.","journal-title":"J Comput Assist Tomogr"},{"key":"2257_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/RTI.0000000000000612","volume":"37","author":"V Palmisano","year":"2022","unstructured":"Palmisano V, Cossa S, Esposito A, Bassareo PP, Porcu M, Cau R, et al. Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: Differences in Global and Segmental Myocardial Strain by Cardiac Magnetic Resonance Feature Tracking. J Thorac Imaging. 2022;37:49\u201357. https:\/\/doi.org\/10.1097\/RTI.0000000000000612.","journal-title":"J Thorac Imaging"},{"key":"2257_CR16","doi-asserted-by":"publisher","first-page":"oead043","DOI":"10.1093\/ehjopen\/oead043","volume":"3","author":"AKC Lo","year":"2023","unstructured":"Lo AKC, Mew T, Mew C, Guppy-Coles K, Dahiya A, Ng A, et al. Exaggerated myocardial torsion may contribute to dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur Heart J Open. 2023;3:oead043. https:\/\/doi.org\/10.1093\/ehjopen\/oead043.","journal-title":"Eur Heart J Open"},{"key":"2257_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcmg.2024.07.011","volume":"18","author":"OA Smiseth","year":"2025","unstructured":"Smiseth OA, Rider O, Cvijic M, Valkovi\u010d L, Remme EW, Voigt J-U. Myocardial Strain Imaging. JACC: Cardiovasc Imaging. 2025;18:340\u201381. https:\/\/doi.org\/10.1016\/j.jcmg.2024.07.011.","journal-title":"JACC: Cardiovasc Imaging"},{"key":"2257_CR18","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10554-019-01631-8","volume":"35","author":"A Satriano","year":"2019","unstructured":"Satriano A, Heydari B, Guron N, Fenwick K, Cheung M, Mikami Y, et al. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2019;35:1913\u201324. https:\/\/doi.org\/10.1007\/s10554-019-01631-8.","journal-title":"Int J Cardiovasc Imaging"},{"key":"2257_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","volume":"35","author":"SF Nagueh","year":"2022","unstructured":"Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A, et al. Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2022;35:533\u201369. https:\/\/doi.org\/10.1016\/j.echo.2022.03.012.","journal-title":"J Am Soc Echocardiogr"},{"key":"2257_CR20","doi-asserted-by":"publisher","unstructured":"Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proceedings. 2006;81:459\u201367. https:\/\/doi.org\/10.4065\/81.4.459","DOI":"10.4065\/81.4.459"},{"key":"2257_CR21","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739\u201391. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391.","journal-title":"Eur Heart J"},{"key":"2257_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/hrt.2007.118018","volume":"94","author":"DH Kwon","year":"2007","unstructured":"Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2007;94:1295\u2013301. https:\/\/doi.org\/10.1136\/hrt.2007.118018.","journal-title":"Heart"},{"key":"2257_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.echo.2016.03.003","volume":"29","author":"JJ Silbiger","year":"2016","unstructured":"Silbiger JJ. Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights. J Am Soc Echocardiogr. 2016;29:622\u201339. https:\/\/doi.org\/10.1016\/j.echo.2016.03.003.","journal-title":"J Am Soc Echocardiogr"},{"key":"2257_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/HCO.0000000000001067","volume":"38","author":"J Malcolmson","year":"2023","unstructured":"Malcolmson J, Shipolini A, Mohiddin S, Savvatis K. The Mitral Valve in Hypertrophic Cardiomyopathy. Curr Opin Cardiol. 2023;38:415\u201323. https:\/\/doi.org\/10.1097\/HCO.0000000000001067.","journal-title":"Curr Opin Cardiol"},{"key":"2257_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/ejechocard\/jep217","volume":"11","author":"D Muraru","year":"2010","unstructured":"Muraru D, Badano LP, Piccoli G, Gianfagna P, Del Mestre L, Ermacora D, et al. Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography. Eur Heart J - Cardiovasc Imaging. 2010;11:359\u201368. https:\/\/doi.org\/10.1093\/ejechocard\/jep217.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"2257_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/cdt.2017.06.01","volume":"8","author":"D Muraru","year":"2018","unstructured":"Muraru D, Niero A, Rodriguez-Zanella H, Cherata D, Badano L. Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Ther. 2018;8:101\u201317. https:\/\/doi.org\/10.21037\/cdt.2017.06.01.","journal-title":"Cardiovasc Diagn Ther"},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.amjcard.2007.10.032","volume":"101","author":"CJ Harrigan","year":"2008","unstructured":"Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, et al. Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy. Am J Cardiol. 2008;101:668\u201373. https:\/\/doi.org\/10.1016\/j.amjcard.2007.10.032.","journal-title":"Am J Cardiol"},{"key":"2257_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11748-018-0915-0","volume":"66","author":"S Manabe","year":"2018","unstructured":"Manabe S, Kasegawa H, Arai H, Takanashi S. Management of systolic anterior motion of the mitral valve: a mechanism-based approach. Gen Thorac Cardiovasc Surg. 2018;66:379\u201389. https:\/\/doi.org\/10.1007\/s11748-018-0915-0.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2257_CR29","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/ehjci\/jey095","volume":"19","author":"JD Groarke","year":"2018","unstructured":"Groarke JD, Galazka PZ, Cirino AL, Lakdawala NK, Thune JJ, Bundgaard H, et al. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers. Eur Heart J - Cardiovasc Imaging. 2018;19:1109\u201316. https:\/\/doi.org\/10.1093\/ehjci\/jey095.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"2257_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/ehjci\/jead078","volume":"24","author":"D Filomena","year":"2023","unstructured":"Filomena D, Vandenberk B, Dresselaers T, Willems R, Van Cleemput J, Olivotto I, et al. Apical papillary muscle displacement is a prevalent feature and a phenotypic precursor of apical hypertrophic cardiomyopathy. Eur Heart J - Cardiovasc Imaging. 2023;24:1009\u201316. https:\/\/doi.org\/10.1093\/ehjci\/jead078.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"2257_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11517-017-1674-2","volume":"56","author":"X Zhao","year":"2018","unstructured":"Zhao X, Tan RS, Tang HC, Leng S, Zhang J-M, Zhong L. Analysis of three-dimensional endocardial and epicardial strains from cardiac magnetic resonance in healthy subjects and patients with hypertrophic cardiomyopathy. Med Biol Eng Comput. 2018;56:159\u201372. https:\/\/doi.org\/10.1007\/s11517-017-1674-2.","journal-title":"Med Biol Eng Comput"},{"key":"2257_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.stemcr.2018.11.015","volume":"12","author":"R Cohn","year":"2019","unstructured":"Cohn R, Thakar K, Lowe A, Ladha FA, Pettinato AM, Romano R, et al. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations. Stem Cell Rep. 2019;12:71\u201383. https:\/\/doi.org\/10.1016\/j.stemcr.2018.11.015.","journal-title":"Stem Cell Rep"},{"key":"2257_CR33","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jcmg.2010.08.003","volume":"3","author":"RB Weiner","year":"2010","unstructured":"Weiner RB, Hutter AM, Wang F, Kim J, Weyman AE, Wood MJ, et al. The Impact of Endurance Exercise Training on Left Ventricular Torsion. JACC: Cardiovasc Imaging. 2010;3:1001\u20139. https:\/\/doi.org\/10.1016\/j.jcmg.2010.08.003.","journal-title":"JACC: Cardiovasc Imaging"},{"key":"2257_CR34","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.amjcard.2014.03.020","volume":"113","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, et al. Differences in Global and Regional Left Ventricular Myocardial Mechanics in Various Morphologic Subtypes of Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Ventricular Septal Myotomy\/Myectomy. Am J Cardiol. 2014;113:1879\u201385. https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.020.","journal-title":"Am J Cardiol"},{"key":"2257_CR35","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ccd.26472","volume":"88","author":"M Prasad","year":"2016","unstructured":"Prasad M, Geske JB, Sorajja P, Ommen SR, Schaff HV, Gersh BJ, et al. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction. Cathet Cardio Intervent. 2016;88:962\u201370. https:\/\/doi.org\/10.1002\/ccd.26472.","journal-title":"Cathet Cardio Intervent"},{"key":"2257_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ejhf.3120","volume":"26","author":"E Bertero","year":"2024","unstructured":"Bertero E, Chiti C, Schiavo MA, Tini G, Costa P, Todiere G, et al. Real-World Candidacy to Mavacamten in a Contemporary Hypertrophic Obstructive Cardiomyopathy Population. Eur J Heart Fail. 2024;26:59\u201364. https:\/\/doi.org\/10.1002\/ejhf.3120.","journal-title":"Eur J Heart Fail"},{"key":"2257_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ehjci\/jev227","volume":"17","author":"M Obokata","year":"2016","unstructured":"Obokata M, Nagata Y, Wu VC-C, Kado Y, Kurabayashi M, Otsuji Y, et al. Direct comparison of cardiac magnetic resonance feature tracking and 2D\/3D echocardiography speckle tracking for evaluation of global left ventricular strain. Eur Heart J Cardiovasc Imaging. 2016;17:525\u201332. https:\/\/doi.org\/10.1093\/ehjci\/jev227.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2257_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.amjcard.2025.01.032","volume":"242","author":"Z Abood","year":"2025","unstructured":"Abood Z, Jan MF, Ashraf M, Hundal P, Howard L, Sanders H, et al. Real-World Assessment of Mavacamten\u2019s Impact on Left Ventricular Systolic and Diastolic Functions in Obstructive Hypertrophic Cardiomyopathy: A 1-Year Single-Center Observational Study. Am J Cardiol. 2025;242:68\u201374. https:\/\/doi.org\/10.1016\/j.amjcard.2025.01.032.","journal-title":"Am J Cardiol"},{"key":"2257_CR39","doi-asserted-by":"publisher","first-page":"e017185","DOI":"10.1161\/CIRCIMAGING.124.017185","volume":"17","author":"MY Desai","year":"2024","unstructured":"Desai MY, Okushi Y, Gaballa A, Wang Q, Geske JB, Owens AT, et al. Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial. Circ Cardiovasc Imaging. 2024;17:e017185. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.017185.","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02257-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:07:26Z","timestamp":1776247646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02257-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8315722\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tongji Medical College (Approval No.: 2022-S013-(1\u20134)) and complied with the latest Declaration of Helsinki (2013, Fortaleza, Brazil). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}